about
Shortening and modifying the 1513 MSP-1 peptide's alpha-helical region induces protection against malariaStructural and immunological analysis of circumsporozoite protein peptides: a further step in the identification of potential components of a minimal subunit-based, chemically synthesised antimalarial vaccine3D structure determination of STARP peptides implicated in P. falciparum invasion of hepatic cellsBinding activity, structure, and immunogenicity of synthetic peptides derived from Plasmodium falciparum CelTOS and TRSP proteinsIMPIPS: the immune protection-inducing protein structure concept in the search for steric-electron and topochemical principles for complete fully-protective chemically synthesised vaccine developmentElongating modified conserved peptides eliminates their immunogenicity and protective efficacy against P. falciparum malaria.Synthetic vaccine update: applying lessons learned from recent SPf66 malarial vaccine physicochemical, structural and immunological characterization.Structural and immunological principles leading to chemically synthesized, multiantigenic, multistage, minimal subunit-based vaccine development.Towards the development of a fully protective Plasmodium falciparum antimalarial vaccine.Functionally relevant proteins in Plasmodium falciparum host cell invasion.TCR-contacting residues orientation and HLA-DRβ* binding preference determine long-lasting protective immunity against malaria.Monosaccharides modulate HCV E2 protein-derived peptide biological properties.Immunogenicity and protectivity of Plasmodium falciparum EBA-175 peptide and its analog is associated with alpha-helical region shortening and displacement.Protecting capacity against malaria of chemically defined tetramer forms based on the Plasmodium falciparum apical sushi protein as potential vaccine components.Protective immunity provided by a new modified SERA protein peptide: its immunogenetic characteristics and correlation with 3D structure.A Large Size Chimeric Highly Immunogenic Peptide Presents Multistage Plasmodium Antigens as a Vaccine Candidate System against Malaria.Conserved Binding Regions Provide the Clue for Peptide-Based Vaccine Development: A Chemical Perspective.Gauche(+) side-chain orientation as a key factor in the search for an immunogenic peptide mixture leading to a complete fully protective vaccine.A single amino acid change in the Plasmodium falciparum RH5 (PfRH5) human RBC binding sequence modifies its structure and determines species-specific binding activity.Fitting modified HRP-I peptide analogue 3D structure into HLA-DR molecules induces protection against Plasmodium falciparum malaria.High non-protective, long-lasting antibody levels in malaria are associated with haplotype shifting in MHC-peptide-TCR complex formation: a new mechanism for immune evasion.The high immunogenicity induced by modified sporozoites' malarial peptides depends on their phi (ϕ) and psi (ψ) angles.Specific β-Turns Precede PPIIL Structures Binding to Allele-Specific HLA-DRβ1* PBRs in Fully-Protective Malaria Vaccine Components.
P50
Q27643097-5EF09C9E-11CA-4C18-B63D-0FEEC5D2D306Q27652547-A2D11F74-DC59-49F4-8C07-C78D675D0E26Q27662791-D9A95787-E7FA-4983-B4F7-526282A90B35Q27674543-B4E0A0D7-57AA-4C71-94BE-8B0F8D3FDC25Q30373743-C40E3861-E0FE-4893-A882-65CBABFA9E96Q33214973-50349652-BF15-459A-8368-679B95CA5204Q33280848-ADD6BE72-01D2-47B5-9038-E9F393C9CADEQ37857826-47FFD8DC-DE83-487B-8039-EC43EFF7475CQ38059750-8000DAFE-0141-4EDE-B071-B7731D4974C6Q39106485-9B96022D-E619-463F-B940-B7B90876090CQ39642203-76742E5F-E56B-4836-800E-DA884A5C0809Q43036066-711241BF-15F6-421F-BC13-5E9CE91CE5BEQ44689320-0CF6D5D8-F936-4EB0-B642-D3C2DD7F0AD8Q45167684-59563108-F894-430F-8DC9-C98D42868CB6Q46895272-AD019425-83E6-484F-A3DD-EA611FA2EE41Q47177933-796209D6-7C14-4026-AA51-6193E4CE4B30Q47303165-9C9A2307-82F4-458F-94CA-A4C48D175E83Q47858214-9E2FA7F4-C3F5-43D0-846E-0C133F7FDF21Q47995418-18CD4475-67B8-4ADA-85A9-4DD108249C94Q47997018-F8E113B2-A16A-444D-BEE8-D5B2F9D080F9Q48024421-8EC5EA5D-E7A7-4219-AE8C-82487F839F95Q48025225-937FD953-8CD3-49D4-A70A-72F5B0D40F42Q52571067-787047DE-340C-4161-9B51-06D8E4B3A9A7
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Adriana Bermudez
@ast
Adriana Bermudez
@en
Adriana Bermudez
@es
Adriana Bermudez
@nl
type
label
Adriana Bermudez
@ast
Adriana Bermudez
@en
Adriana Bermudez
@es
Adriana Bermudez
@nl
prefLabel
Adriana Bermudez
@ast
Adriana Bermudez
@en
Adriana Bermudez
@es
Adriana Bermudez
@nl
P106
P1153
7006102417
P21
P31
P496
0000-0003-2669-7259